Is NewAmsterdam Pharma Co. NV NAMS stock halal to invest in?

No, as of August 2026, NewAmsterdam Pharma Co. NV stock (NAMS) is not currently classified as a Shariah compliant stock. This verdict follows the screening methodology of AAOIFI (the Accounting and Auditing Organization for Islamic Financial Institutions), whose Shariah Standard No. 21 is the leading global benchmark for screening halal stocks. To qualify as halal under this standard, a company must keep non-permissible income below 5% of total revenue, keep both interest-bearing investments and interest-bearing debt below 30% of market capitalisation, and have no impermissible preference share structure. NewAmsterdam Pharma Co. NV currently does not meet the threshold for the non-permissible income screen. Because screenings are refreshed monthly as new financial reports are published, a non-compliant stock can regain compliant status if its financial structure changes. You can track the latest status of NewAmsterdam Pharma Co. NV and discover Shariah compliant alternatives among the halal stocks in the Tabadulat app.

How often is NewAmsterdam Pharma Co. NV NAMS reviewed for Shariah compliance?

Tabadulat reviews NewAmsterdam Pharma Co. NV NAMS for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for NewAmsterdam Pharma Co. NV reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Non Permissible Income criteria?

No, as of August 2026, NewAmsterdam Pharma Co. NV stock (NAMS) does not pass the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. NewAmsterdam Pharma Co. NV's income from non-permissible sources currently exceeds this 5% ceiling, which makes the stock non-compliant on this criterion regardless of how it performs on the other screens. The screen is reassessed monthly, so the status can change when the company releases new financial statements.

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of August 2026, NewAmsterdam Pharma Co. NV stock (NAMS) passes the AAOIFI interest-bearing investments screen. Under AAOIFI Shariah Standard No. 21, the cash a company places in interest-earning instruments (such as conventional deposits, bonds, treasury bills and money-market funds) must remain below 30% of its market capitalisation. This limit ensures shareholders are not materially profiting from riba (interest). NewAmsterdam Pharma Co. NV's interest-bearing investments are currently within the 30% threshold. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of August 2026, NewAmsterdam Pharma Co. NV stock (NAMS) passes the AAOIFI interest-bearing debt screen. Under AAOIFI Shariah Standard No. 21, a company's borrowings that accrue interest (conventional bank loans, bonds and similar riba-based financing) must remain below 30% of its market capitalisation. This cap limits shareholders' exposure to interest-based leverage. NewAmsterdam Pharma Co. NV's interest-bearing debt is currently within the 30% threshold. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for NewAmsterdam Pharma Co. NV NAMS stock?

NewAmsterdam Pharma Co. NV (NAMS) is currently classified as not Shariah compliant, so no dividend purification factor applies, because purification factors are calculated only for stocks that pass the AAOIFI screens. Purification (tazkiyah) is the practice of donating to charity the small portion of dividend income that stems from incidental non-permissible sources, such as interest earned on a compliant company's cash deposits. For non-compliant stocks the issue is not purification but eligibility: under AAOIFI Shariah Standard No. 21 the stock does not currently qualify as a halal investment. If NewAmsterdam Pharma Co. NV returns to compliance in a future monthly screening, its purification factor will be published alongside its updated status in the Tabadulat app.

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Preference Share screen?

Yes, as of August 2026, NewAmsterdam Pharma Co. NV stock (NAMS) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. NewAmsterdam Pharma Co. NV has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

NewAmsterdam Pharma Co. NV

NASDAQ

Shariah-Compliant

Not Shariah

NAMS

About

NewAmsterdam Pharma Co. NV

NAMS

NewAmsterdam Pharma Co. N.V. is a pharmaceutical company focused on the research, development, and commercialization of transformative therapies addressing cardiovascular diseases. The company's primary mission is to innovate in the cardiovascular space by introducing medications that meet the evolving needs of patients worldwide. Notably, NewAmsterdam Pharma is at the forefront of developing novel treatments aimed at reducing cardiovascular risk and improving patient outcomes. Operating within the life sciences sector, the company leverages advanced scientific research and development capabilities to push forward its pipeline of projects. By concentrating specifically on cardiovascular therapies, NewAmsterdam Pharma aims to significantly impact a critical area of healthcare that affects millions globally. In the financial markets, the company represents an essential player within the pharmaceutical industry, focused on addressing unmet medical needs. Its work has substantial implications for both the healthcare sector and broader economic landscapes, illustrating the importance of continuous innovation in tackling global health challenges.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://www.newamsterdampharma.com

NAMS

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

NewAmsterdam Pharma Co. NV

About

NewAmsterdam Pharma Co. NV

NAMS

Frequently asked questions

Is NewAmsterdam Pharma Co. NV NAMS stock halal to invest in?

How often is NewAmsterdam Pharma Co. NV NAMS reviewed for Shariah compliance?

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Non Permissible Income criteria?

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Interest Bearing Investments criteria?

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Interest Bearing Debt criteria?

What is the dividend purification factor for NewAmsterdam Pharma Co. NV NAMS stock?

Does NewAmsterdam Pharma Co. NV NAMS pass the AAOIFI Preference Share screen?

Can I buy NewAmsterdam Pharma (NAMS) stock on Tabadulat?

Open your account.

Deposit.

Screen.